Parasiticidal effect of chemotherapy in alveolar hydatid disease: Review of experience with mebendazole and albendazole in alaskan eskimos

Clinical Infectious Diseases

Volumn 15, Issue 2, 1992, Pages 234-249

  Wilson, J F ^a,b,c   Rausch, R L ^a,b,c   McMahon, B J ^a,b,c   Schantz, P M ^a,b,c  

^a ALASKA NATIVE MEDICAL CENTER   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; MEBENDAZOLE;

ANIMAL TISSUE; CALCIFICATION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; ECHINOCOCCUS MULTILOCULARIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYDATID CYST; IMMUNOHISTOCHEMISTRY; LIVER HYDATID CYST; METASTASIS; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; SURVIVAL TIME; TUMOR VOLUME; VOLE;

ADULT; AGED; AGED, 80 AND OVER; ALASKA; ALBENDAZOLE; ECHINOCOCCOSIS; ESKIMOS; FOLLOW-UP STUDIES; HUMAN; MEBENDAZOLE; MIDDLE AGE; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0026632546     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/clinids/15.2.234     Document Type: Article

References (36)

1. Zhuravlev VA. Operabel’nost’ pri al’veokokkoze pecheni. Khirurgiia 1980;6:71-5
2. Rausch R, Schiller EL. Hydatid disease (Echinococcosis) in Alaska and the importance of rodent intermediate hosts. Science 1951; 113:57-8
3. Rausch RL, Wilson JF, Schantz PM. A programme to reduce the risk of infection by Echinococcus multilocularis: the use of praziquantel to control the cestode in a village in the hyperendemic region of Alaska. Ann Trop Med Parasitol 1990;84:239-50
4. Gottstein B, Schantz PM, Wilson JF. Serological screening for Echinococcus multilocularis infections with ELISA [letter]. Lancet 1985;1:1097-8
5. Lanier AP, Trujillo DE, Schantz PM, Wilson JF, Gottstein B, McMahon BJ. Comparison of serologic tests for the diagnosis and follow-up of alveolar hydatid disease. Am J Trop Med Hyg 1987;37:609-15
6. 2 ELISA) and clinical significance. Am J Trop Med Hyg 1987; 36:576-85
7. Heath DD, Chevis RAF. Mebendazole and hydatid cysts [letter]. Lancet 1974;2:218-9
8. Braithwaite PA. Long-term high-dose mebendazole for cystic hydatid disease of liver: failure in two cases. Aust N Z J Surg 1981;51:23-7
9. Bryceson ADM, Cowie AGA, MacLeod C, et al. Experience with mebendazole in the treatment of inoperable hydatid disease in England. Trans R Soc Trop Med Hyg 1982;76:510-8
10. Braithwaite PA, Allan RJ, Dawson M, Roberts MS, Watson TR. Cyst and host tissue concentrations of mebendazole in patients undergoing surgery for hydatid disease. Med J Aust 1983;2:383-4
11. Gil-Grande LA, Boixeda D, Garcia-Hoz F, et al. Treatment of liver hydatid disease with mebendazole: a prospective study of thirteen cases. Am J Gastroenterol 1983;78:584-8
12. Wilson JF, Davidson M, Rausch RL. A clinical trial of mebendazole in the treatment of alveolar hydatid disease. Am Rev Respir Dis 1978;118:747-57
13. Wilson JF, Rausch RL. Alveolar hydatid disease: a review of clinical features of 33 indigenous cases of Echinococcus multilocularis infection in Alaskan Eskimos. Am J Trop Med Hyg 1980;29:1340-55
14. Wilson JF, Rausch RL. Mebendazole and alveolar hydatid disease. Ann Trop Med Parasitol 1982;76:165-73
15. Morris DL, Dykes PW, Marriner S, et al. Albendazole: objective evidence of response in human hydatid disease. JAMA 1985;253: 2053-7
16. Luder PJ, Robotti G, Meister FP, Bircher J. High oral doses of mebendazole interfere with growth of larval Echinococcus multilocularis lesions. J Hepatol 1985;1:369-77
17. Okelo GBA. Hydatid disease: research and control in Turkana: III. Albendazole in the treatment of inoperable hydatid disease in Kenya -a report on 12 cases. Trans R Soc Trop Med Hyg 1986;80:193-5
18. Chinnery JB, Morris DL. Effect of albendazole sulphoxide on viability of hydatid protoscoleces in vitro. Trans R Soc Trop Med Hyg 1986;80:815-7
19. Morris DL, Buckley J, Gregson R, Worthington BS. Magnetic resonance imaging in hydatid disease. Clin Radiol 1987;38:141-4
20. Marriner SE, Morris DL, Dickson B, Bogan JA. Pharmacokinetics of albendazole in man. Eur J Clin Pharmacol 1986;30:705-8
21. Rowley AH, Shulman ST, Donaldson JS, Schantz PM. Albendazole treatment of recurrent echinococcosis. Pediatr Infect Dis J 1988;7:666-7
22. Todorov T, Vutova K, Petkov D, Balkanski G. Albendazole treatment of multiple cerebral hydatid cysts: case report. Trans R Soc Trop Med Hyg 1988;82:150-2
23. Ammann R, Tschudi K, von Ziegler M, et al. Langzeitverlauf bei 60 Patienten mit alveolärer Echinokokkose unter Dauertherapie mit Mebendazol (1976-85). Klin Wochenschr 1988;66:1060-73
24. Horton RJ. Chemotherapy of Echinococcus infection in man with albendazole. Trans R Soc Trop Med Hyg 1989;83:97-102
25. Strohmaier WL, Bichler KH, Wilbert DM, Seitz HM. Alveolar echino-coccosis with involvement of the ureter and testis. J Urol 1990;144:733-4
26. Rausch RL, Wilson JF, McMahon BJ, O’Gorman MA. Consequences of continuous mebendazole therapy in alveolar hydatid disease: with a summary of a 10-year clinical trial. Ann Trop Med Parasitol 1986;80:403-19
27. Wilson JF, Rausch RL, McMahon BJ, Schantz PM, Trujillo DE, O’Gorman MA. Albendazole therapy in alveolar hydatid disease: a report of favorable results in two patients after short-term therapy. Am J Trop Med Hyg 1987;37:162-8
28. Rausch RL, Wilson JF. Rearing of the adult Echinococcus multilocularis Leuckart, 1863, from sterile larvae from man. Am J Trop Med Hyg 1973;22:357-60
29. Furuya K. An established cell line of larval Echinococcus multilocularis. Int J Parasitol 1991;21:233-40
30. Condon J, Rausch RL, Wilson JF. Application of the avidin-biotin immunohistochemical method for the diagnoses of alveolar hydatid disease from tissue sections. Trans R Soc Trop Med Hyg 1988;82:731-5
31. Smyth JD, Barrett NJ. Procedures for testing the viability of human hydatid cysts following surgical removal, especially after chemotherapy. Trans R Soc Trop Med Hyg 1980;74:649-52
32. Didier D, Weiler S, Rohmer P, et al. Hepatic alveolar echinococcosis: correlative US and CT study. Radiology 1985; 154:179-86
33. Eckert J, Barandun G, Pohlenz J. Chemotherapie der larvalen Echinokokkose bei Labortieren. Schweiz Med Wochenschr 1978; 108: 1104-12
34. Schantz PM, Brandt FH, Dickinson CM, Allen CR, Roberts JM, Eberhard ML. Effects of albendazole on Echinococcus multilocularis infection in the Mongolian jird. J Infect Dis 1990;162:1403-7
35. Woodtli W, Bircher J, Witassek F, Eckert J, Wiithrich B, Ammann RW. Effects of plasma mebendazole concentrations in the treatment of human echinococcosis. Am J Trop Med Hyg 1985;34:754-60
36. Thompson WM, Chisholm DP, Tank R. Plain film roentgenographic findings in alveolar hydatid disease-Echinococcus multilocularis. AJR Am J Roentgenol 1972;116:345-58